These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. Schleiss MR J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834 [TBL] [Abstract][Full Text] [Related]
23. Vaccines for cytomegalovirus. Bernstein DI Infect Disord Drug Targets; 2011 Oct; 11(5):514-25. PubMed ID: 22309618 [TBL] [Abstract][Full Text] [Related]
24. Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection. Schleiss MR J Pediatr; 2007 Dec; 151(6):564-70. PubMed ID: 18035130 [No Abstract] [Full Text] [Related]
25. Vaccination against the human cytomegalovirus. Plotkin SA; Boppana SB Vaccine; 2019 Nov; 37(50):7437-7442. PubMed ID: 29622379 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus. Dempsey AF; Pangborn HM; Prosser LA Vaccine; 2012 Jun; 30(27):4060-6. PubMed ID: 22525796 [TBL] [Abstract][Full Text] [Related]
35. Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59). Marshall BC; Adler SP Viral Immunol; 2003; 16(4):491-500. PubMed ID: 14733736 [TBL] [Abstract][Full Text] [Related]
36. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection. Farrell HE; Bruce K; Stevenson PG J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701 [TBL] [Abstract][Full Text] [Related]
37. Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection. Lanzieri TM; Bialek SR; Ortega-Sanchez IR; Gambhir M Vaccine; 2014 Jun; 32(30):3780-6. PubMed ID: 24837782 [TBL] [Abstract][Full Text] [Related]
38. A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection. Hogea C; Dieussaert I; Van Effelterre T; Guignard A; Mols J Hum Vaccin Immunother; 2015; 11(7):1788-802. PubMed ID: 25984886 [TBL] [Abstract][Full Text] [Related]
39. Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on. Hassan J; Connell J Clin Exp Immunol; 2007 Aug; 149(2):205-10. PubMed ID: 17635529 [TBL] [Abstract][Full Text] [Related]
40. Progress toward an elusive goal: current status of cytomegalovirus vaccines. Schleiss MR; Heineman TC Expert Rev Vaccines; 2005 Jun; 4(3):381-406. PubMed ID: 16026251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]